Figure 2.
Outcomes of the entire cohort of patients treated with commercial axi-cel or tisacel from the French DESCAR-T registry. (Left) Absolute number contribution to patient outcomes (N = 957). (Right) Proportion of early and late NRM among overall NRM. Early NRM is defined by NRM occurring before day 28 after CAR T-cell injection; late NRM is defined by NRM occurring beyond day 28 after CAR T-cell injection.